ArticleCurrent computer-aided drug design2025

Astragaloside IV Overcomes Anlotinib Resistance in Non-small Cell Lung Cancer through miR-181a-3p/UPR-ERAD Axis.

Lihuai Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.